Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Feb
19
2021
Will the Final Chapter Come? FDA’s Action Plan for Oversight of Artificial Intelligence/Machine Learning-Based Medical Software Greenberg Traurig, LLP
Feb
18
2021
Certain Cannabis Workers Are Not Protected by the NLRA Barnes & Thornburg LLP
Feb
18
2021
Recent FTC Settlement Serves as Reminder For Digital Health Developers Sheppard, Mullin, Richter & Hampton LLP
Feb
18
2021
New EU Transparency Regulation to Apply from March 27, 2021 Keller and Heckman LLP
Feb
18
2021
Hawaii Proposes Tax on Sugar-Sweetened Beverages Keller and Heckman LLP
Feb
18
2021
What is M-E-A-T? Womble Bond Dickinson (US) LLP
Feb
17
2021
FDA Responds to Questions About Heavy Metals in Baby Food Keller and Heckman LLP
Feb
16
2021
Ninth Circuit Affirms Dismissal of Breast Implant Cases on Preemption Grounds Faegre Drinker
Feb
16
2021
Proposed Legislation Seeks to Clarify that Kombucha Beverages are Not Alcohol Keller and Heckman LLP
Feb
16
2021
Top Ten Legal Considerations for Use and/or Development of Artificial Intelligence in Health Care Katten
Feb
16
2021
Therapeutic Drugs and the Blood Brain Barrier: How to Break on Through to the Other Side Womble Bond Dickinson (US) LLP
Feb
15
2021
Chancery Court Enforces Merger Agreement Milestone Payment Despite Time and Cost to Bring Experimental Drug to Market K&L Gates
Feb
14
2021
Amgen v. Sanofi – How Wands Factors make Biotech Claims “Magically” Disappear
Feb
12
2021
Double Whammy: Fifth Circuit Affirms Dismissal of Suit Against Generic and Brand-Name Drug Manufacturers Faegre Drinker
Feb
12
2021
Bias in Healthcare Algorithms Epstein Becker & Green, P.C.
Feb
11
2021
CSPI Alleges Infant Formula Misbranding to FDA Keller and Heckman LLP
Feb
11
2021
Heavy Metals In Baby Food Pose Concern For Baby Food Industry CMBG3 Law
Feb
11
2021
Virginia is for... Cannabis Lovers… in 2024? Womble Bond Dickinson (US) LLP
Feb
10
2021
Idaho Congressman Proposes “Salmon and Energy Concept” To Breach Lower Snake River Dams Beveridge & Diamond PC
Feb
10
2021
Federal Circuit Agrees to Reconsider Ruling in GSK v. Teva Drug Patent Case Sheppard, Mullin, Richter & Hampton LLP
Feb
10
2021
Starbucks Frappuccino Is Latest Target of Deceptive Vanilla Labeling Lawsuit Keller and Heckman LLP
Feb
9
2021
Legal Challenge to the FDA’s Approval of “Blood” in Plant-Based Meat Womble Bond Dickinson (US) LLP
Feb
9
2021
California Wineries Required to Comply with New Statewide Waste Discharge Order Allen Matkins Leck Gamble Mallory & Natsis LLP
Feb
9
2021
Gerber and Plum Hit with Consumer Class-Action Lawsuits in Wake of Congressional Report on Heavy Metals in Baby Food Keller and Heckman LLP
Feb
9
2021
Working Together, FDA, NTIA, and Domain Registries Take Down 30 Websites Illegally Selling Opioids Mintz
Feb
8
2021
FDA Announces New Sampling Plan for Romaine Lettuce Grown in the Yuma, Arizona Growing Region Keller and Heckman LLP
Feb
5
2021
Regulating Third-Party Food Delivery Services During COVID-19 Hunton Andrews Kurth
Feb
5
2021
Sargento Foods Faces Two Labeling Suits Regarding “No Antibiotics” Claims on Cheeses Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins